Sodium-glucose cotransporter 2 (SGLT-2) inhibition and kidney protection: Does improvement in kidney hypoxia play a role?

Sodium-glucose cotransporter 2 (SGLT-2) inhibition and kidney protection: Does improvement in kidney hypoxia play a role?

Bibliographic Details
Main Author:	Michel Burnier
Format:	Article
Language:	English
Published:	Elsevier 2021-07-01
Series:	EClinicalMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589537021002637

Similar Items

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibition in Kidney Transplant Recipients with Diabetes Mellitus
by: Moritz Mahling, et al.
Published: (2019-08-01)

The effect of sodium/glucose cotransporter 2 (SGLT2) inhibition on the urinary proteome.
by: David Cherney, et al.
Published: (2017-01-01)

Sodium-Glucose Cotransporter (SGLT2) inhibitors: A new Era in renovascular protection
by: Adel E. Berbari
Published: (2020-12-01)

Sodium-Glucose Linked Cotransporter-2 Inhibition Does Not Attenuate Disease Progression in the Rat Remnant Kidney Model of Chronic Kidney Disease.
by: Yanling Zhang, et al.
Published: (2016-01-01)

Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: A Clinician’s Guide
by: Simes BC, et al.
Published: (2019-10-01)

GI inflammation Increases Sodium-Glucose Cotransporter Sglt1
by: Jiyoung Park, et al.
Published: (2019-05-01)

Sodium Glucose Cotransporter 2 (SGLT2) Plays as a Physiological Glucose Sensor and Regulates Cellular Contractility in Rat Mesangial Cells.
by: Masanori Wakisaka, et al.
Published: (2016-01-01)

Inhibition of Sodium-GlucoseCotransporter 2 with Dapagliflozin in Han: SPRD Rats with Polycystic Kidney Disease
by: Daniel Rodriguez, et al.
Published: (2015-12-01)

Sodium-Glucose Cotransporter 2 (SGLT-2) Inhibitor drugs: Assessment of safety in Fasting Diabetics
by: Muhammad Imran Hasan Khan, et al.
Published: (2021-03-01)

Sodium-Glucose Cotransporter Inhibition Prevents Oxidative Stress in the Kidney of Diabetic Rats
by: Horacio Osorio, et al.
Published: (2012-01-01)

Quality of methodological reporting of randomized clinical trials of sodium-glucose cotransporter-2 (sglt2) inhibitors
by: Hadeel Alfahmi, et al.
Published: (2017-01-01)

Review on sodium-glucose cotransporter 2 inhibitor (SGLT2i) in diabetes mellitus and heart failure
by: Akshyaya Pradhan, et al.
Published: (2019-01-01)

SODIUM GLUCOSE COTRANSPORT(SGLT2) INHIBITORS. A NEW TYPE OF ANTIDIABETICS BY ORAL ADMINISTRATION
by: Gloria Viñes, et al.
Published: (2014-12-01)

Sodium glucose cotransporter (SGLT)-2 inhibitors alleviate the renal stress responsible for sympathetic activation
by: Motoaki Sano
Published: (2020-07-01)

Ertugliflozin: a sodium-glucose cotransporter-2 (SGLT-2) inhibitor for glycemic control in type 2 diabetes
by: Derosa G, et al.
Published: (2018-09-01)

Effect of Sodium-Glucose Cotransport Inhibition on Polycystic Kidney Disease Progression in PCK Rats.
by: Sarika Kapoor, et al.
Published: (2015-01-01)

Sodium glucose transporter 2 (SGLT2) inhibition and ketogenesis
by: Sanjay Kalra, et al.
Published: (2015-01-01)

Dietary and genetic influence on regulation of intestinal sodium/glucose cotransporter 1 (SGLT1)
by: Batchelor, Daniel James
Published: (2010)

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis
by: Hang-Long Li, et al.
Published: (2021-05-01)

Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors from Natural Products: Discovery of Next-Generation Antihyperglycemic Agents
by: Chang-Ik Choi
Published: (2016-08-01)

Renal glucose handling in diabetes and sodium glucose cotransporter 2 inhibition
by: Resham Raj Poudel
Published: (2013-01-01)

Sodium-Glucose Cotransporter-2 (SGLT-2) Attenuates Serum Uric Acid (SUA) Level in Patients with Type 2 Diabetes
by: Mazhar Hussain, et al.
Published: (2021-01-01)

Role of sodium/glucose cotransporter inhibition on a rat model of angiotensin II–dependent kidney damage
by: Humberto Reyes-Pardo, et al.
Published: (2019-08-01)

Correction to: Sodium–glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta‑analysis
by: Hang-Long Li, et al.
Published: (2021-09-01)

A Call for a New Paradigm for Diabetes Care in the Era of Sodium–Glucose Cotransporter 2 Inhibitors (SGLT2i)
by: Sun H. Kim, et al.
Published: (2020-07-01)

Update on the impact of sodium-glucose cotransporter inhibitors in diabetic kidney disease progression
by: Ana Carolina Cruz Afonso Romano
Published: (2021)

Safety of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2-I) During the Month of Ramadan in Muslim Patients with Type 2 Diabetes
by: Alaaeldin Bashier, et al.
Published: (2018-03-01)

Sodium–Glucose Cotransporter 2 Inhibitors and Kidney Outcomes: True Renoprotection, Loss of Muscle Mass or Both?
by: Adrian Post, et al.
Published: (2020-05-01)

Combined effect of sodium–glucose cotransporter 2 and dipeptidyl peptidase‐4 inhibitors for diabetic kidney disease
by: Shin‐ichi Araki
Published: (2020-01-01)

Association between sodium-glucose cotransporter 2 (SGLT2) inhibitors and lower extremity amputation: A systematic review and meta-analysis.
by: James Heyward, et al.
Published: (2020-01-01)

Effect of sodium-glucose cotransporter 2 (SGLT2) inhibitors on left ventricular remodelling and longitudinal strain: a prospective observational study
by: Sergio Gamaza-Chulián, et al.
Published: (2021-09-01)

Inhibition of sodium‐glucose cotransporter 2 ameliorates renal injury in a novel medaka model of nonalcoholic steatohepatitis‐related kidney disease
by: Takuro Nagoya, et al.
Published: (2019-12-01)

Multi-Organ Protective Effects of Sodium Glucose Cotransporter 2 Inhibitors
by: Hidekatsu Yanai, et al.
Published: (2021-04-01)

Synthesis of C-aryl D-glucofuranosides as Potent, Selective Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitors for Type 2 Diabetes Treatment
by: Ya-Wen Liw, et al.
Published: (2011)

Impact of sodium–glucose cotransporter 2 inhibitors on renal function in participants with type 2 diabetes and chronic kidney disease with normoalbuminuria
by: Akinobu Nakamura, et al.
Published: (2020-01-01)

d-Allose is absorbed via sodium-dependent glucose cotransporter 1 (SGLT1) in the rat small intestine
by: Kunihiro Kishida, et al.
Published: (2021-09-01)

Inhibition of Sodium Glucose Cotransporters Improves Cardiac Performance
by: Álvaro García-Ropero, et al.
Published: (2019-07-01)

Sodium-glucose cotransporter 2 inhibition and health benefits: The Robin Hood effect
by: Sanjay Kalra, et al.
Published: (2016-01-01)

Sodium-glucose cotransporter-2 inhibition and the insulin: Glucagon ratio: Unexplored dimensions
by: Sanjay Kalra, et al.
Published: (2015-01-01)

Investigating the Role of Sodium-Glucose Cotransporter 2 Modulation in Metabolic Syndrome Induced-Chronic Kidney Disease Mouse Model
by: Cheff, Véronique
Published: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1que9tjdt865dbkuamd80onrd2